Literature DB >> 10644723

PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit.

S Swift1, P J Sheridan, L Covic, A Kuliopulos.   

Abstract

Signal transfer between the protease-activated PAR1 thrombin receptor and membrane-associated heterotrimeric G proteins is mediated by protein-protein interactions. We constructed a yeast signaling system that resolves domain-specific functions of binding from coupling in the Galpha subunit. The endogenous yeast Galpha subunit, Gpa1, does not bind to PAR1 and served as a null structural template. N- and C-terminal portions of mammalian G(i2) and G(16) were substituted back into the Gpa1 template and gain-of-function assessed. The C-terminal third of G(16), but not of G(i2), provides sufficient interactions for coupling to occur with PAR1. The N-terminal two-thirds of G(i2) also contains sufficient determinants to bind and couple to PAR1 and overcome the otherwise negative or missing interactions supplied by the C-terminal third of Gpa1. Replacement of the N-terminal alpha-helix of G(i2), residues 1-34, with those of Gpa1 abolishes coupling but not binding to PAR1 or to betagamma subunits. These data support a model that the N-terminal alphaN helix of the Galpha subunit is physically interposed between PAR1 and the Gbeta subunit and directly assists in transferring the signal between agonist-activated receptor and G protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644723     DOI: 10.1074/jbc.275.4.2627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides.

Authors:  Lidija Covic; Amy L Gresser; Joyce Talavera; Steven Swift; Athan Kuliopulos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4.

Authors:  María de la Fuente; Daniel N Noble; Sheetal Verma; Marvin T Nieman
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

3.  Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics.

Authors:  Ping Zhang; Andrew J Leger; James D Baleja; Rajashree Rana; Tiffany Corlin; Nga Nguyen; Georgios Koukos; Andrew Bohm; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

4.  Enhanced contractile response to thrombin in the pregnant rat myometrium.

Authors:  Y Shintani; K Hirano; J Nishimura; H Nakano; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.

Authors:  Marvin T Nieman; Alvin H Schmaier
Journal:  Biochemistry       Date:  2007-06-27       Impact factor: 3.162

6.  Effects of mutations in the N terminal region of the yeast G protein alpha-subunit Gpa1p on signaling by pheromone receptors.

Authors:  M Roginskaya; S M Connelly; K S Kim; D Patel; M E Dumont
Journal:  Mol Genet Genomics       Date:  2004-02-07       Impact factor: 3.291

7.  Matrix metalloprotease-1a promotes tumorigenesis and metastasis.

Authors:  Caitlin J Foley; Chi Luo; Katie O'Callaghan; Philip W Hinds; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

8.  Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies.

Authors:  Federica Lombardi; Kalyan Golla; Darren J Fitzpatrick; Fergal P Casey; Niamh Moran; Denis C Shields
Journal:  PLoS Comput Biol       Date:  2015-04-15       Impact factor: 4.475

9.  The G protein betagamma subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin.

Authors:  Nebojsa Knezevic; Mohammad Tauseef; Tracy Thennes; Dolly Mehta
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.